Deep 6 AI was founded with the mission to revolutionize patient recruitment for clinical trials through advanced artificial intelligence technology. The company's vision is to expedite and enhance the clinical trial process by efficiently matching patients to trials in minutes rather than months. Deep 6 AI offers a comprehensive platform that aids in trial design, site selection, patient recruitment, on-study monitoring, and post-study analysis. Their market focus is on healthcare providers, pharmaceutical companies, and clinical research organizations aiming to streamline and optimize clinical trials.
Notable affiliated individuals and investors include industry experts and venture capital firms specializing in healthcare technology. Deep 6 AI has achieved significant milestones, including the successful recruitment of over 23 million patients for various clinical trials. Their impact on the industry is profound, reducing the time and cost associated with patient matching and site selection, thereby accelerating the development of new treatments and therapies.
